“Assessment Of Quality-Of-Life Improvement In Severe Haemophilia-A With Inhibitor Patients Receiving Emicizumab Prophylaxis – Hospital Based Prospective Observational Study - Original Research Article” (2025) The Review of Diabetic Studies, pp. 579–583. doi:10.70082/9n07nr44.